Vascular Graft Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Hemodialysis Access Graft, Endovascular Stent Graft, Peripheral Vascular Graft, Coronary Artery By-pass Graft), By Application (Aneurysms, Kidney Failure, Vascular Occlusion, Coronary Artery Diseases, Other Applications), By Region and Competition, 2020-2030F

Market Overview

Global Vascular Graft Market has valued at USD 1.29 Billion in 2024 and is expected to reach USD 1.87 Billion by 2030 with a CAGR of 7.31% during the forecast period. The growth of the global vascular graft market is driven by the increasing prevalence of vascular diseases, such as aneurysms, peripheral artery disease (PAD), and coronary artery disease (CAD). These diseases are caused by the narrowing or blockage of blood vessels, which can lead to serious health problems, such as stroke, heart attack, and limb amputation. Vascular grafts are used to replace or repair damaged or diseased blood vessels. The market is also driven by the increasing number of surgical procedures, such as endovascular aneurysm repair (EVAR) and coronary artery bypass grafting (CABG). EVAR is a minimally invasive procedure used to treat abdominal aortic aneurysms (AAAs), while CABG is a surgery used to bypass blocked coronary arteries. Vascular grafts are used in both of these procedures.

Moreover, key market players and research institutions are dedicated to the creation of cutting-edge grafts tailored to meet essential requirements. They are actively seeking funds and investments to advance the development of vascular access grafts. For instance, in May 2022, the California Institute for Regenerative Medicine (CIRM) awarded UC Davis a USD 3 million grant to facilitate the development of an intelligent and long-lasting vascular graft specifically designed for hemodialysis patients. These industry advancements are anticipated to drive significant growth within the segment in the coming years.

Key Market Drivers

Increasing Prevalence of Cardiovascular Diseases

A primary driver of the global vascular graft market is the escalating prevalence of cardiovascular diseases (CVDs) worldwide. These diseases, including coronary artery disease, peripheral arterial disease, and aortic aneurysms, are responsible for a significant global disease burden. As lifestyle factors, such as poor dietary habits and sedentary lifestyles, become more prevalent, the incidence of CVDs continues to rise. This surge in cardiovascular diseases necessitates a higher demand for vascular grafts for surgical interventions, ultimately boosting the market. Cardiovascular diseases encompass a range of conditions, including coronary artery disease, peripheral arterial disease, and aortic aneurysms, which collectively represent a substantial global health concern. Several factors contribute to the rising prevalence of CVDs, all of which, in turn, fuel the demand for vascular grafts. Firstly, changes in lifestyle habits have played a significant role. Sedentary lifestyles, unhealthy dietary choices, and increased stress levels have become increasingly prevalent in modern society. These factors contribute to the development of risk factors like obesity, hypertension, and diabetes, all of which are known precursors to cardiovascular diseases.

According to the CDC, Heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups. One person dies every 33 seconds from cardiovascular disease. In 2022, 702,880 people died from heart disease. That's the equivalent of 1 in every 5 deaths. As individuals continue to adopt these lifestyles, the incidence of CVDs is expected to rise, boosting the need for vascular graft procedures. Furthermore, the aging population is a crucial contributor to the increased prevalence of cardiovascular diseases. As people age, they become more susceptible to vascular conditions due to factors like atherosclerosis and the natural wear and tear of blood vessels over time. With advances in healthcare, the global demographic is experiencing an increase in life expectancy, leading to a larger population of elderly individuals. This demographic shift directly correlates with a higher demand for vascular grafts as a means to address age-related vascular issues.

Aging Population

The world's aging population is another critical factor driving the global vascular graft market. As individuals age, they become more prone to vascular conditions and diseases due to factors like atherosclerosis and weakened vessel walls. The aging population is a significant driving force behind the growth of the global vascular graft market. As demographics shift and more individuals worldwide enter their senior years, the prevalence of vascular diseases and conditions associated with aging increases. This demographic trend has profound implications for healthcare systems and has spurred a growing demand for vascular graft procedures. According to World Health Organization, by 2030, 1 in 6 people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. By 2050, the world’s population of people aged 60 years and older will double (2.1 billion). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million.

With advancing age, individuals become more susceptible to a range of vascular issues, including atherosclerosis, aneurysms, and peripheral arterial disease. The natural aging process can lead to the weakening of blood vessel walls, reduced elasticity, and the development of plaques within arteries. As a result, older adults are at a higher risk of developing vascular diseases that may require surgical intervention. Moreover, the elderly population often presents them with complex medical histories, making vascular graft procedures a crucial component of their healthcare. These procedures can be essential in addressing age-related vascular complications and improving overall quality of life for older individuals. As life expectancy continues to increase due to advances in healthcare and improved living conditions, the number of elderly individuals seeking vascular graft surgeries is on the rise. This surge in demand for vascular grafts has a direct impact on the global market, with medical device manufacturers and healthcare providers working to meet the needs of this growing demographic.

Advancements in Vascular Surgery Techniques

Advancements in vascular surgery techniques have expanded the applicability and effectiveness of vascular grafts. Minimally invasive procedures, endovascular interventions, and hybrid surgeries have become more prevalent, reducing the invasiveness and recovery time associated with vascular graft procedures. These advancements have encouraged more patients to consider vascular grafts as a viable treatment option, thus driving market expansion. One significant advancement is the widespread adoption of minimally invasive surgical techniques in vascular surgery. Procedures such as endovascular surgery and angioplasty have become more common, offering several advantages over traditional open surgeries. Minimally invasive techniques result in smaller incisions, reduced blood loss, shorter hospital stays, and faster recovery times. These factors make vascular graft procedures more appealing to both patients and healthcare providers. Endovascular interventions, in particular, have revolutionized the treatment of vascular diseases. These procedures involve the use of catheters, guidewires, and stents to repair or replace damaged blood vessels from within. For many patients, this approach eliminates the need for open surgery altogether, reducing the associated risks and complications. Endovascular techniques have expanded the scope of conditions that can be effectively treated with vascular grafts, driving demand in the market. Hybrid surgeries, which combine open and endovascular approaches, have also become more prevalent. These procedures offer the advantages of both techniques, allowing surgeons to tailor treatments to individual patient needs. For complex vascular cases, hybrid surgeries have become a valuable tool, further increasing the demand for vascular grafts.

Download Free Sample Report

Key Market Challenges

Stringent Regulatory Hurdles

Regulatory bodies across the globe, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have strict standards for medical devices, including vascular grafts. The approval process is intricate, ensuring that any product reaching the market is safe and effective. While these standards are essential for patient safety, they also lengthen the product development cycle, delaying market entry and increasing costs for manufacturers. The regulatory approval process for vascular grafts is intricate and time-consuming. It involves rigorous testing, clinical trials, and documentation to demonstrate the product's safety and effectiveness. The extensive paperwork and stringent quality control standards can lead to extended development timelines and increased costs, deterring smaller companies from entering the market. Moreover, differing regulations in various regions add complexity to the process, as manufacturers must navigate multiple regulatory frameworks to gain market approval worldwide. This not only raises costs but also results in delays in bringing innovative vascular graft products to market, limiting options for patients and clinicians.

High Cost of Vascular Graft Procedures

Vascular graft procedures, particularly the more technologically advanced ones, can be expensive. The costs associated with procuring the grafts, the specialized equipment required, and the expertise of the surgical team can be prohibitive. This makes it challenging for patients in lower to middle-income countries to access these procedures, limiting market expansion. This includes the cost of procuring the graft materials, specialized medical equipment, operating room expenses, and the fees of highly skilled surgical teams. For many patients, especially those in lower to middle-income brackets, the expenses associated with vascular graft procedures can be prohibitively high, leading to delayed or deferred treatments. Furthermore, the cost factor also impacts healthcare systems and providers. High procedure costs can strain healthcare budgets and affect reimbursement policies, creating challenges for hospitals and clinics to offer these services. Additionally, in regions with limited healthcare resources, the high cost can lead to disparities in access to vascular graft procedures, resulting in unequal patient outcomes.

Complications Associated with Vascular Grafts

No surgical procedure is without risks. Vascular graft surgeries can lead to complications such as graft infection, occlusion, or graft failure. The potential for these complications can deter patients and clinicians from opting for graft procedures, which can hinder the growth of the vascular graft market. These complications can result from factors like improper graft sizing, poor surgical technique, or underlying patient health issues. The occurrence of these adverse events can deter both patients and healthcare providers from considering or recommending vascular graft procedures. Graft infections, in particular, pose a serious threat, as they can lead to systemic infections and may necessitate graft removal or replacement. Thrombosis and occlusion can result in the loss of graft patency, requiring additional interventions or surgeries. These complications not only increase healthcare costs but also cause patient distress and potential morbidity or mortality. Moreover, the need for ongoing surveillance and potential revision surgeries in cases of complications can add to the overall financial burden and inconvenience for patients.

Key Market Trends

Technological Advancements

One of the primary drivers of growth in the vascular graft market is the continuous advancement of technology. Innovations in graft materials, manufacturing techniques, and design have improved the overall performance and durability of vascular grafts. For example, the development of grafts made from bioengineered and tissue-engineered materials has reduced the risk of graft-related complications and improved long-term patency. Additionally, the use of graft coatings that resist infection and thrombosis has enhanced the safety and effectiveness of these medical devices. As technology continues to evolve, vascular grafts are becoming more reliable and versatile, increasing their adoption in various vascular surgeries Furthermore, the use of graft coatings has gained prominence in recent years. These coatings are designed to resist infection and thrombosis, enhancing the safety and efficacy of vascular grafts. They provide an additional layer of protection for patients undergoing vascular graft procedures, reducing the risk of complications and improving overall patient outcomes.

Minimally Invasive Procedures

The adoption of minimally invasive procedures in vascular surgery is a significant trend contributing to the growth of the vascular graft market. Minimally invasive techniques, such as endovascular surgeries and angioplasty, offer several advantages over traditional open surgeries, including smaller incisions, reduced blood loss, shorter hospital stays, and faster recovery times. These benefits have made vascular graft procedures more appealing to both patients and healthcare providers. As minimally invasive techniques become more widely adopted, the demand for vascular grafts used in these procedures is expected to increase, driving market growth. Minimally invasive procedures, including endovascular surgeries and angioplasty, involve smaller incisions, reduced blood loss, shorter hospital stays, and faster postoperative recovery times compared to their open counterparts. These advantages make vascular graft procedures more appealing to patients, as they often experience less pain and a quicker return to their daily lives.

Hybrid Surgeries

Hybrid surgeries, which combine open and endovascular approaches, are becoming increasingly prevalent in vascular surgery. These procedures offer the advantages of both techniques, allowing surgeons to tailor treatments to individual patients’ needs. For complex vascular cases, hybrid surgeries have become a valuable tool, further increasing the demand for vascular grafts. The flexibility and versatility offered by hybrid procedures make vascular grafts a crucial component in addressing a wide range of vascular conditions, thus boosting the market.

Segmental Insights

Application Insights

Based on Application, the Kidney Failure segment emerged as the dominant player in the global market for Vascular Graft Market and is anticipated to grow in the forecast period. This is attributed to several factors including the rising incidences of kidney failure. Kidney failure is a critical medical condition where vascular grafts play a pivotal role. Patients with end-stage renal disease often require hemodialysis, a process that involves the creation of arteriovenous fistulas or grafts to provide access for dialysis. As the prevalence of kidney diseases and the need for dialysis treatments increase worldwide, the demand for vascular grafts designed for kidney failure applications rises in parallel.

Product Insights

Based on Product, the Hemodialysis Access Graft segment emerged as the dominant player in the global market for Vascular Graft Market. This is attributed to the to several compelling factors such as  hemodialysis access grafts play a pivotal role in the management of end-stage renal disease (ESRD). Patients with ESRD often require regular hemodialysis treatments to filter waste and excess fluids from their blood. Hemodialysis access grafts serve as a crucial conduit for creating vascular access points, allowing for efficient hemodialysis procedures. As the incidence of ESRD continues to rise globally due to factors like aging populations and the increasing prevalence of conditions such as diabetes and hypertension, the demand for hemodialysis access grafts has seen significant growth. 

Download Free Sample Report

Regional Insights

Based on the Region, North America holds the largest market share in the Vascular Graft Market, primarily due to the high prevalence of cardiovascular diseases (CVDs), well-established healthcare infrastructure, and rising adoption of advanced vascular graft technologies. According to the CDC, in the United States, someone has a heart attack every 40 seconds. Every year, about 805,000 people in the United States have a heart attack.3 Of these, 605,000 are a first heart attack, and 200,000 happen to be people who have already had a heart attack. About 1 in 5 heart attacks are silent—the damage is done, but the person is not aware of it. The United States and Canada are at the forefront, driven by increasing cases of coronary artery disease (CAD), peripheral artery disease (PAD), and aortic aneurysms, which require surgical interventions using vascular grafts. The availability of cutting-edge medical facilities, a high number of vascular surgeries, and favorable reimbursement policies further boost market growth. Additionally, the presence of leading vascular graft manufacturers and continuous R&D investments in biomaterial-based and tissue-engineered grafts enhance market expansion. The growing geriatric population, coupled with an increasing number of lifestyle-related disorders such as diabetes and hypertension, also contributes to the dominance of North America in the vascular graft market. Moreover, the increasing incidence of vascular diseases worldwide, including peripheral artery disease (PAD), coronary artery disease (CAD), chronic kidney disease (CKD), and aneurysms, serves as a significant catalyst for the market growth. For instance, according to Center for Disease Control and Prevention (CDC), in North America, approximately 6.5 million people aged 40 years and over live with the peripheral arterial disease (PAD).

Recent Developments

• In December 2024, The U.S. Food and Drug Administration approved Symvess, the first acellular tissue engineered vessel indicated for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization (restoration of blood flow) is needed to avoid imminent limb loss, and autologous vein graft is not feasible.
• In October 2024, Humacyte provided updates on the commercial launch of Symvess, their FDA-approved bioengineered vascular conduit for extremity arterial injury. The company has set the price at $29,500 per unit and has assembled a highly experienced sales team of ten members, each with over 15 years of experience in medical device and biotech sales.
• In September 2024, W.L. Gore & Associates Inc. has released the 10-centimeter configuration for its hybrid vascular graft. The new size is designed to access deeper vessels, which expands treatment and makes it easier for physicians performing vascular procedures, the company claims.
• In September 2023, MicroPort Scientific Corporation obtained registration approval from the Thailand Food and Drug Administration (TFDA) for three products: the Castor Branched Aortic Stent-Graft, the Hercules Thoracic Stent Graft System, and the Minos Abdominal Aortic Stent-Graft.
• In April 2023, Abbott Laboratories acquired Cardiovascular Systems, Inc., a medical device company known for its innovative atherectomy system used in the treatment of peripheral and coronary artery disease.
• In October 2021, Terumo Aortic gained approval for the Tero abdominal aortic stent grafts. Abdominal aortic aneurysms will benefit from the use of this Japanese device.
• In March 2021, Vascular Grafts Solutions (VGS) Ltd. announced its  VIOLA, a novel device for clampless proximal anastomosis in coronary artery bypass grafting (CABG), has received marketing authorization from the US FDA.

Key Market Players

• Abbott Laboratories
• Braun Melsungen AG
• Becton, Dickinson and Company (Bard Peripheral Vascular Inc.)
• Cardinal Health (Cordis Corporation)
• Cook Medical
• Endologix Inc.
• Getinge Group
• LeMaitre Vascular Inc.
• Medtronic PLC
• Terumo Medical Corporation.

Report Scope:

In this report, the Global Vascular Graft Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Vascular Graft Market, By Product:

o   Hemodialysis Access Graft Endovascular Stent Graft

o   Peripheral Vascular Graft

o   Coronary Artery By-pass Graft

• Vascular Graft Market, By Drug Application:

o   Aneurysms

o   Kidney Failure

o   Vascular Occlusion

o   Coronary Artery Diseases

o   Other Applications

• Vascular Graft Market, By Region:

o   North America

§  United States

§  Mexico

§  Canada

o   Europe

§  France

§  Germany

§  United Kingdom

§  Italy

§  Spain

o   Asia-Pacific

§  China

§  India

§  South Korea

§  Japan

§  Australia

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East and Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vascular Graft Market Market.

Available Customizations:

Global Vascular Graft Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Vascular Graft Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com